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Commentary
Despite substantial advances in the management of cardiovascular disease, it remains a major cause of morbidity and mortality worldwide [1] . Globally, cardiovascular disease is expected to account for over 23 million deaths by the year 2030, mostly attributable to an increasing incidence in low and middle income countries [2] . Registry, NCDR) [8] .
However, only a minority of countries have clinical registries of cardiovascular disease, and not all are mandatory which can lead to potential participation bias. A recent review of the literature suggested that most central and eastern European countries did not have published acute coronary syndrome care and outcomes data [9] . Of those that did, there was evidence for wide variation in emergency strategies for the reperfusion of ST-segment elevation myocardial infarction (STEMI) [10] .
Moreover, a significant East-West gap across European countries was evident in recent comparative studies of aggregate national and regional registry survey data despite recent improvements in the quality of care and increased rates of reperfusion strategies for STEMI [11, 12] . Explanations for geographical variations in emergency strategies and mortality rates are not always clear. Many studies have focused on differences in social, economic, cultural and clinical risk factors. Indeed in the MONICA study improvements in mortality rates during a 10-year period showed a greater relationship with a decline in pre-hospital mortality rates [13] . Beyond the quality of care provided in hospitals, differences in pre-hospital logistics, management and time delays strongly influence patients' outcome. This is particularly true for the Central and Eastern European countries [12, 14, 15] .
Differences in social and economic factors play a crucial role in risk profile, acute coronary care and secondary prevention and need to be considered when comparing Participating hospitals are instructed to record data from consecutive hospital admissions and to register these data into standardised electronic charts on an internet-based database system before being uploaded to the data bank of the international coordinating centre [16] .
To date this international clinical registry has revealed substantial opportunities for healthcare improvement among patients with acute STEMI (as reflected in long times to reperfusion and high 30 day mortality rates), and reported the efficiency of early blockade following acute coronary syndrome (associated with improved left ventricular systolic function and higher in-hospital survival rates) [14, 17] . A recent study from the ISACS-TC registry reviewed current practice in antithrombotic therapy and reported that STEMI patients who fail to receive any reperfusion therapy benefit in terms of survival from unfractioned heparin -clopidogrel combination therapy without significant increases in risk of bleeding as compared to combined enoxaparin and clopidogrel therapy [18] . These findings are of note if we consider that non-reperfused STEMI patients are a major concern despite advances in emergency management. Moreover, recommendations in current guidelines for nonreperfused STEMI patients are based mostly on expert opinions rather than on evidence from clinical trials or clinical registries.
Whilst there are several reports of between country comparisons of acute myocardial infarction care and outcomes, typically these have either compared high performing countries with each other, [19] [20] [21] eastern countries with each other, [14, 16] or used aggregated data [11, 22, 23] to compare many countries. There are limited contemporary comparisons of care for acute myocardial infarction between eastern and western European countries which have used patient-level data derived from a range of clinical registries [10] . International comparisons contextualise the quality of care provided in different countries and highlight opportunities for improvement.
Moreover, variation between hospitals in quality of care and clinical outcomes provides useful insight into the performance of national health systems. For example, comparative research has shown that specific aspects of cardiovascular care are better and vary less between hospitals in Sweden than in the United Kingdom and that this is associated with many potentially avoidable deaths in the United Kingdom [19, 20] . In addition, there is huge scope for novel research -using individual patient data meta-analyses to study rare cardiovascular events, repurposing clinical data for the design of multinational studies and the conduct of efficient registry-based randomised controlled trials [24] .
It is clear that a new approach to the international study of cardiovascular care is justified. Clinical registries are not only important to assess the effectiveness and safety of health interventions but are critical for the assessment of the quality of healthcare systems and more so, for quality improvement. For this reason, promotion of comparable national clinical registries, mandatory rather than volunteer, using similar definitions for diseases, interventions and outcomes should be fostered across Europe [25] . This is an urgent need for Eastern European countries, where there may be a greater need of cyclical clinical evaluation for research and particularly for identification of targets for quality improvement initiatives. 
